Aug 9 (Reuters) - Klaria Pharma Holding Ab (Publ) KLAR.ST
* Klaria signs exclusive development, license and supply agreement with purdue pharma (canada) for acute treatment of opioid overdose (kl-00514)
* Klaria pharma holding says purdue pharma (canada) will pay co combination of upfront, milestone, success-based payments plus a royalty on sales
* Klaria pharma holding -staged, success-based payments during development phase and registration and approval process will total approximately $2.3 million